Auckland, NZ (PRWEB) September 01, 2013
Dr Richard Teague, spokesperson for Regenex Laboratories, says they have discovered how to use selected proteins within an ovine placenta extract base and combine it with peptides and signaling molecules designed to ‘wake up’ dormant stem cells in the body.
"Peptides are considered the future of medicine," he said. "And with this technology, using fractionated OVP in combination with peptides, we can provide an answer to HIV by reactivating the patient’s immune system."
"Up until now these products have only used in the controversial anti-ageing field, but now we have evidence that they actually do re-activate a person's stem cells. The stem cells are intelligent in that they seek out the area of most need in the body and repair it."
Dr Teague says the injectable cannot eradicate HIV from the body but it could potentially end the disease, as it provides a healthy immune system so patients can handle normal infections."
More than 33 million people have been diagnosed with HIV worldwide.
If clinical trials are successful, one initial 12 week course followed by a single dose every 3-4 months could be effective enough to replace the multiple therapies they currently need.
The key to the Immune Booster IM product is the filtering process which is used in the production process. The company has been able to achieve a filtration of less than 50,000 Dalton units, meaning the 5mg dose can be safely injected intramuscular, rather than having to be done intravenously.
"We have spent several years developing the production process and this is cutting edge technology now available to consumers worldwide."
"With HIV you have 2 options. You either have to eliminate the viru
Copyright©2012 Vocus, Inc.
All rights reserved